Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Cerebrus develops novel animal satiety model

Aug. 22, 1997

Non-parenteral insulin formulations for treating IDDM

Aug. 21, 1997

U.S. patent allowed for erectile dysfunction therapy

Aug. 21, 1997

Phase IV trial of Redux

Aug. 21, 1997

Squalene synthase inhibitors in development at Sankyo

Aug. 21, 1997

Antidiabetic herbomineral formulation tested in Indian patients

Aug. 20, 1997

Rapid-acting insulin analog under clinical evaluation

Aug. 20, 1997

Imidazoline derivative displays potent antidiabetic effects in rats

Aug. 20, 1997

DPP-IV inhibition in the treatment of diabetes

Aug. 20, 1997

Repaglinide gets expedited review status in U.S

Aug. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...